SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (1)9/28/1999 10:31:00 AM
From: opalapril  Read Replies (2) of 75
 
Three more sites that attempt to catalogue pending FDA applications. These may be known to many, but perhaps others will find them useful.

FDA Drug Approvals List
The FDA Drug Approvals list is updated weekly as a service by CDER's Division of Data Management and Services. The Drug approvals on this list are verified and published as they become available and at any given time may not contain all FDA drug approvals. [Chemical type and therapeutic potential codes are not verified prior to publication]. For a complete listing of new drug approvals for a particular month, please refer to the Approved Drug Products with Therapeutic Equivalence Evaluations Monthly Additions and Deletions. For approval information prior to June 1996, see the FDA Drug and Device Product Approval List.
Updated September 27, 1999
fda.gov

Bioportfolio
"To meet the increasing demand of scientists, investors, commerce and government for timely, accurate and commercially useful information and intelligence on biotechnology companies, technologies and products world-wide."
bioportfolio.com

ReCap (with P-1, P-2, and P-3 bar charts)
ReCap's mission is to ensure availability of adequate resources for deserving biotechnology enterprises by providing comprehensive and timely advice and analysis related to the environment for corporate and product development and alliance formation. ReCap's clients include more than 150 biotechnology and pharmaceutical companies, plus several universities, investment banking and venture firms active in the biotechnology area.
recap.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News